The Role of 4-[2-(Methylamino)ethyl]phenol Hydrochloride in Pharmaceutical Synthesis
In the intricate world of pharmaceutical development, the quality and availability of chemical intermediates are paramount. 4-[2-(Methylamino)ethyl]phenol Hydrochloride, identified by its CAS number 13062-76-5, stands out as a vital compound, serving as a key building block in the synthesis of various Active Pharmaceutical Ingredients (APIs). Understanding its significance and how to procure it efficiently is a core competency for R&D scientists and procurement professionals alike.
Chemical Profile and Purity Standards
4-[2-(Methylamino)ethyl]phenol Hydrochloride is a white to off-white crystalline powder, a form that is convenient for handling and integration into complex synthetic processes. With a molecular formula of C9H13NO.ClH and a molecular weight of approximately 187.67 g/mol, it is a stable compound. Its purity, often specified at 99%, is a critical factor for its use in pharmaceutical applications, where even trace impurities can have significant downstream effects on drug efficacy and safety. As a reputable supplier of 4-[2-(Methylamino)ethyl]phenol Hydrochloride, we ensure that our product consistently meets these high purity standards.
Applications in API Synthesis and Drug Discovery
The primary application of 4-[2-(Methylamino)ethyl]phenol Hydrochloride is as an intermediate in the synthesis of APIs. Its unique chemical structure, featuring a phenolic hydroxyl group and a secondary amine, allows for a range of chemical modifications and reactions essential for creating sophisticated drug molecules. Researchers leverage this compound in early-stage drug discovery and subsequent process development, contributing to the creation of novel therapeutics targeting various diseases.
For professionals looking to buy 4-[2-(Methylamino)ethyl]phenol Hydrochloride for their research or manufacturing, identifying a reliable manufacturer in China is a strategic advantage. Chinese chemical suppliers are known for their ability to produce high-purity intermediates at competitive prices, often with efficient turnaround times and robust quality control systems.
Why Partner with a Chinese Manufacturer for CAS 13062-76-5?
When you search for a supplier for CAS 13062-76-5, you’ll find numerous options. However, partnering with a specialized manufacturer in China offers several distinct benefits:
- Cost-Effectiveness: Direct sourcing from manufacturers often leads to significantly lower prices compared to intermediaries, optimizing your budget for R&D or production.
- Quality Assurance: Reputable Chinese manufacturers invest heavily in quality control, often holding certifications like ISO and GMP, ensuring product consistency and reliability.
- Scalability: They possess the capacity to meet both small-scale research needs and large-scale industrial production demands.
- Expertise: Many manufacturers have extensive experience in chemical synthesis, offering technical support and custom solutions.
If you are considering where to purchase pharmaceutical intermediates, exploring options from established Chinese chemical companies is a wise move. They are adept at meeting international quality standards and can provide the necessary documentation for regulatory compliance.
In conclusion, 4-[2-(Methylamino)ethyl]phenol Hydrochloride (CAS 13062-76-5) is a critical component in modern pharmaceutical synthesis. By selecting a trusted manufacturer and supplier, particularly from China, you can ensure access to high-quality materials at competitive prices, thereby accelerating your drug discovery and development efforts.
Perspectives & Insights
Molecule Vision 7
“Expertise: Many manufacturers have extensive experience in chemical synthesis, offering technical support and custom solutions.”
Alpha Origin 24
“If you are considering where to purchase pharmaceutical intermediates, exploring options from established Chinese chemical companies is a wise move.”
Future Analyst X
“They are adept at meeting international quality standards and can provide the necessary documentation for regulatory compliance.”